Wingwomen Technologies Secures FDA Exemption for Redesign of Obstetric Forceps
Redesign aims to improve maternal safety by modernizing centuries-old obstetric tools.
San Francisco, California, United States, 12th May 2025 – Wingwomen Technologies, a leader in maternal health innovation, announced today that its latest medical device—the company’s redesign of obstetric forceps—has received an FDA exemption, marking a major milestone in FemTech. This brings the total number of exempted redesigns across Wingwomen Inc. and its sister company Wingwomen Technologies to seven, including four exemptions previously granted for improvements to the vaginal speculum.
This latest exemption represents the first known women led modernization of obstetric forceps—an instrument that has remained virtually unchanged since the 1600s. The updated design reflects modern understandings ...